Jordan Baumhardt, Ph.D.

Jordan Baumhardt, Ph.D., serves as a research analyst for Eventide, and an associate for Eventide’s private fund. Dr. Baumhardt has research responsibilities for healthcare investments at Eventide.

Prior to joining Eventide, Dr. Baumhardt worked at LifeSci Capital in New York, where he served as an associate and then lead analyst, covering companies in oncology and autoimmune spaces. During Dr. Baumhardt’s doctoral program, he worked at life sciences venture firm Flagship Pioneering. He also worked at Reata Pharmaceuticals in the strategy department and is the co-founder and chief scientific officer of Peak Research Group, LLC.

Dr. Baumhardt holds a Ph.D. in biophysics & pharmacology from the University of Texas Southwestern Medical Center and a B.S. in biochemistry and molecular biology from Illinois State University.